|
2005
|
Invention
|
N-substituted pyrrolopyridinones active as kinase inhibitors.
Compounds represented by formula ... |
|
2004
|
Invention
|
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiot... |
|
|
Invention
|
Method for estimating or predicting the anti-tumor activity of a compound and for estimating or p... |
|
|
Invention
|
Crystalline polymorphic form of irinotecan hydrochloride.
This invention relates to a novel crys... |
|
|
Invention
|
Pyridylpyrrole derivatives active as kinase inhibitors. Pyridylpyrrole derivatives of formula (I)... |
|
|
Invention
|
Pyrimidylpyrrole derivatives active as kinase inhibitors. Pyrimidylpyrrole derivatives of formula... |
|
|
Invention
|
Method for detecting contaminants in pharmaceutical anthracycline products. The present invention... |
|
|
Invention
|
Method for detecting contaminants in pharmaceutical products.
The present invention relates to a... |
|
|
Invention
|
Method and apparatus for automated swab sample analysis. A method for the analysis of cleaning sa... |
|
|
Invention
|
Fluorine nmr spectroscopy for biochemical screening. High-Throughput Screening (HTS) of large com... |
|
|
Invention
|
Pyrrolo⏧3,4-c]pyrazole derivatives active as kinase inhibitors. Pyrrolo⏧3,4-c]pyrazole ... |
|
|
Invention
|
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharm... |
|
|
Invention
|
Solvent-free anthracycline derivatives. There are provided a method for making highly purified cr... |
|
|
Invention
|
Interaction inhibitors of tcf-4 with beta-catenin. A compound of formula (I) is provided which is... |
|
|
Invention
|
Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors... |
|
|
Invention
|
Truncated forms of human dbf4, complexes with their interacting partners and methods for identifi... |
|
|
Invention
|
Combined therapy comprising an indolopyrrolocarbazole derivative and irinotecan. The present inve... |
|
|
Invention
|
Fused oxabicyclic aminoalcohols as new scaffolds for combinatorial libraries. Fused oxabicyclic a... |
|
|
Invention
|
Disubstituted 1,7-guanines. The present invention relates to 1,7 disubstituted guanines inhibitor... |
|
|
Invention
|
Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor. The present Invention r... |
|
|
Invention
|
Nemorubicin as radiosensitizer in combination with radiation therapy against tumors. The present ... |
|
|
Invention
|
Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharm... |
|
|
Invention
|
Method for predicting the sensitivity to chemotherapy. Herewith described is a novel method for p... |
|
|
Invention
|
A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent. T... |
|
|
Invention
|
Method for treating liver cancer by intrahepatic administration of nemorubicin. The present inven... |
|
|
Invention
|
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmace... |
|
|
Invention
|
Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a poly... |
|
|
Invention
|
Cabergoline for the prophylactic treatment of migraine. The present invention relates to the use ... |
|
|
Invention
|
Chromane derivatives, process for their preparation and their use as antitumor agents. Compounds ... |
|
2003
|
Invention
|
Isotope labeled camptothecin derivatives. The present invention provides isotope stable labeled c... |
|
|
Invention
|
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors. Compounds represented by formula (... |
|
|
Invention
|
Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy. The present inventi... |
|
|
Invention
|
Method for the detection of microorganisms in pharmaceutical products. The present invention disc... |
|
|
Invention
|
Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives. Anthracycline glycosides of for... |
|
|
Invention
|
Crystalline form ii of cabergoline. Crystalline form II of cabergoline, a pharmaceutical composit... |
|
|
Invention
|
Aurones as telomerase inhibitors. The present invention relates to know and novel substituted aur... |
|
|
Invention
|
Method for optimizing therapeutic efficacy of nemorubicin. The present invention relates to produ... |
|
|
Invention
|
Use of substituted acrylolyl distamycin derivatives in combination with demethylating agents, in ... |
|
|
Invention
|
Substituted benzopyranones as telomerase inhibitors. The present invention relates to benzopyrano... |
|
|
Invention
|
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical c... |
|
|
Invention
|
Methods for treating estrogen-dependent disorders. A method of preventing and/or treating estroge... |
|
|
Invention
|
Inhibitors of hcv ns5b polymerase. The present invention provides compounds of Formula I, composi... |
|
|
Invention
|
Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents. ... |
|
2002
|
Invention
|
Process for preparing distamycin derivatives.
|
|
|
Invention
|
Simplified sarcondictyn derivatives as anti-tumor agents.
There are provided sarcodictyin deriv... |
|
|
Invention
|
Human p21-activated kinase 5 polypeptide. The present invention provides a human polypeptide homo... |
|
|
Invention
|
3-arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhi... |
|
|
Invention
|
Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins. A p... |
|
2001
|
Invention
|
Antitumor combined therapy.
A method of treating a human being suffering from a hormone-dependen... |
|
1999
|
Invention
|
Methods to potentiate intravenous estramustine phosphate. Estramustine phosphate is an anti-mitot... |
